Grand Hyatt, São Paulo, Brazil

September 3-4, 2019

0
days
0
hours
0
minutes
0
seconds

Speaker

Gabriela Cezar, CEO and Principal Partner, Panarea Partners

Gabby Cezar founded Panarea Partners in October 2015 with leading US investors to deliver business growth & investments to healthcare and life sciences in Latin America& Africa. She has 10+ years of exclusive focus in growth markets and a remarkable track record in R&D and commercial transactions in countries like Brazil, Argentina, Chile and South Africa, with US$500MM in investments across multiple projects and
programs she created and delivered to Latin America between 2009 and 2015. From 2012 until October 2015, Dr. Cezar served as Senior Director and Head of Pfizer ERDI (External Research & Development Innovation) in Latin America and South Africa. She is also the co-founder and former Chief Scientific Officer of Stemina Biomarker Discovery, in Madison, WI, which commercializes stem cell metabolomics and biomarkers based on her intellectual property at University of Wisconsin-Madison. Stemina is currently advancing the largest US-based clinical trial for a candidate metabolomics-based autism diagnostic.

She was a former senior scientist in Pfizer´s Global Research and Development in Groton, CT, USA, and an Assistant Professor at the University of Wisconsin-Madison (USA), where she was awarded NIH (National Institutes of Health) investments for her research programs in stem cell biology and neurodevelopmental disorders. From 2008-March 2012, as Managing Director Latin America of Burrill & Company, a US – based venture capital firm, Gabby led the fund raising and development of a US$120MM life sciences-focused venture capital fund in Brazil, where Pfizer Ventures
is one of the investors, along with leading regional institutional (BNDES, FINEP, FUNCEF, Investe Rio, Desenvolve SP, CAF, IADB-Fumin) and strategic private investors (Thermo Fisher Scientific, former Life Technologies). Dr. Cezar has been recognized with important global life sciences industry awards, namely a W.E. Upjohn Award and Pfizer Worldwide Innovation Award in 2013, "Top 40 Under 40" from InBusiness magazine, and was named by Forbes Magazine as “one of twelve stem cell revolutionaries” in 2008. She received a Veterinary Medicine degree from UFMS (Brazil), MS from Universidade de Brasilia (Brazil), MS from The University of Edinburgh (Scotland) and a PhD from the University of Wisconsin-Madison (USA).